OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

OBB RSS Feed

  •  

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended for other attorneys. Orange Book Blog is not edited by McAndrews, Held & Malloy, Ltd. ("MHM") or its clients. No part of Orange Book Blog--whether information, commentary, or other--may be attributed to MHM or its clients. MHM represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MHM clients. Orange Book Blog will always strive to be unbiased. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-2017

« Book Review: Generic Pharmaceutical Patent and FDA Law | Main | AstraZeneca Wins Seroquel Case on Summary Judgment; Teva and Sandoz to Appeal »

July 09, 2008

Comments

timothy moriarty

The Federal Circuit, however, found no support for this principle in the specification, prosecution history or the prior art (where such support must be found). Rather, according to the Federal Circuit, Apotex relied exclusively on the declaration of its expert

Sub: Election tools for your state
Message:
Your state is going to play a key role in the upcoming Presidential Election and our tools will help you in making registration to vote easy and obtaining an absentee ballot.
Please check www.StateDemocracy.org for more information

The comments to this entry are closed.